Merit Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.83M | Buy |
11,903
+157
| +1% | +$63.7K | 0.05% | 288 |
|
|
2025
Q1 | $5.84M | Buy |
11,746
+1,895
| +19% | +$943K | 0.09% | 189 |
|
|
2024
Q4 | $5.12M | Buy |
9,851
+3,470
| +54% | +$1.81M | 0.09% | 180 |
|
|
2024
Q3 | $3.95M | Sell |
6,381
-2,061
| -24% | -$1.27M | 0.09% | 176 |
|
|
2024
Q2 | $4.67M | Sell |
8,442
-75
| -0.9% | -$41.5K | 0.1% | 155 |
|
|
2024
Q1 | $4.87M | Buy |
8,517
+4,723
| +124% | +$2.7M | 0.12% | 142 |
|
|
2023
Q4 | $2.01M | Sell |
3,794
-2,920
| -43% | -$1.55M | 0.06% | 207 |
|
|
2023
Q3 | $3.4M | Buy |
6,714
+310
| +5% | +$157K | 0.11% | 141 |
|
|
2023
Q2 | $3.34M | Buy |
6,404
+757
| +13% | +$395K | 0.11% | 145 |
|
|
2023
Q1 | $3.25M | Buy |
5,647
+64
| +1% | +$36.9K | 0.12% | 129 |
|
|
2022
Q4 | $3.07M | Buy |
5,583
+1,486
| +36% | +$818K | 0.11% | 137 |
|
|
2022
Q3 | $2.08M | Sell |
4,097
-1,952
| -32% | -$990K | 0.09% | 151 |
|
|
2022
Q2 | $3.29M | Buy |
6,049
+5,380
| +804% | +$2.92M | 0.1% | 125 |
|
|
2022
Q1 | $395K | Buy |
669
+23
| +4% | +$13.6K | 0.02% | 266 |
|
|
2021
Q4 | $431K | Sell |
646
-77
| -11% | -$51.4K | 0.04% | 184 |
|
|
2021
Q3 | $413K | Buy |
723
+100
| +16% | +$57.1K | 0.04% | 175 |
|
|
2021
Q2 | $314K | Buy |
623
+125
| +25% | +$63K | 0.03% | 203 |
|
|
2021
Q1 | $227K | Sell |
498
-125
| -20% | -$57K | 0.02% | 217 |
|
|
2020
Q4 | $290K | Sell |
623
-3
| -0.5% | -$1.4K | 0.03% | 172 |
|
|
2020
Q3 | $276K | Buy |
+626
| New | +$276K | 0.03% | 184 |
|